1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow BEVZ92: new trials by email Literature Review of BEVZ92 trials Research Report on BEVZ92
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients Bevacizumab biosimilar (BEVZ92), Avastin® (bevacizumab, reference product) - Metastatic Colorectal Cancer (mCRC) | Phase 1 | Completed | mAbxience Research S.L. | 142 | 2014-10-29 | 2019-07-23 |
Colorectal Neoplasms (1) · Neoplasm Metastasis (1)
Argentina (1) · Brazil (1) · India (1) · Spain (1) · Ukraine (1)